SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 47 850 KRW -1.34% Market Closed
Market Cap: 3.7T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

Income Statement

Earnings Waterfall
SK Bioscience Co Ltd

Revenue
201.3B KRW
Cost of Revenue
-146.5B KRW
Gross Profit
54.8B KRW
Operating Expenses
-152B KRW
Operating Income
-97.2B KRW
Other Expenses
54B KRW
Net Income
-43.3B KRW

Income Statement
SK Bioscience Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
223 385
N/A
225 611
+1%
338 321
+50%
423 012
+25%
545 152
+29%
929 001
+70%
903 382
-3%
897 059
-1%
767 283
-14%
456 726
-40%
390 231
-15%
278 429
-29%
419 202
+51%
369 506
-12%
371 179
+0%
371 479
+0%
201 300
-46%
Gross Profit
Cost of Revenue
(128 874)
(130 269)
(169 577)
(184 162)
(226 643)
(358 718)
(358 693)
(349 263)
(295 051)
(217 115)
(197 543)
(165 406)
(256 486)
(227 263)
(224 425)
(213 071)
(146 547)
Gross Profit
94 511
N/A
95 342
+1%
168 744
+77%
238 850
+42%
318 509
+33%
570 283
+79%
544 689
-4%
547 796
+1%
472 232
-14%
239 611
-49%
192 688
-20%
113 023
-41%
162 716
+44%
142 243
-13%
146 754
+3%
158 408
+8%
54 753
-65%
Operating Income
Operating Expenses
(53 519)
(57 631)
(77 318)
(71 595)
(87 321)
(96 063)
(100 432)
(108 505)
(111 988)
(124 597)
(130 615)
(147 449)
(157 563)
(154 231)
(158 809)
(155 093)
(151 989)
Selling, General & Administrative
(28 079)
(30 286)
(40 409)
(36 701)
(43 030)
(46 656)
(47 511)
(51 723)
(52 944)
(62 773)
(64 522)
(65 823)
(67 957)
(62 648)
(64 467)
(65 429)
(68 270)
Research & Development
(24 227)
(24 645)
(35 138)
(33 275)
(42 391)
(47 250)
(50 418)
(53 803)
(55 621)
(57 960)
(61 780)
(76 951)
(84 389)
(85 743)
(86 878)
(81 769)
(75 545)
Depreciation & Amortization
(1 211)
(2 701)
(1 779)
(1 628)
(1 908)
(2 157)
(2 503)
(2 978)
(3 423)
(3 865)
(4 313)
(4 675)
(5 217)
(5 839)
(6 310)
(6 741)
(7 020)
Other Operating Expenses
0
0
9
9
9
0
0
0
0
0
0
0
0
0
(1 154)
(1 154)
(1 154)
Operating Income
40 993
N/A
37 710
-8%
91 426
+142%
167 256
+83%
231 188
+38%
474 220
+105%
444 257
-6%
439 292
-1%
360 244
-18%
115 014
-68%
62 073
-46%
(34 426)
N/A
5 153
N/A
(11 988)
N/A
(12 055)
-1%
3 315
N/A
(97 236)
N/A
Pre-Tax Income
Interest Income Expense
(2 685)
(2 251)
(997)
388
(3 591)
(5 401)
2 587
(1 791)
5 089
31 166
26 979
38 246
33 986
19 311
22 225
19 925
31 839
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
(1 154)
0
0
0
Gain/Loss on Disposition of Assets
(5)
236
254
19
21
24
(112)
(159)
(355)
(435)
(324)
(286)
(97)
(68)
(66)
(113)
(110)
Total Other Income
459
1 597
1 652
3 905
2 518
2 286
2 111
(1 047)
(2 080)
(4 012)
(5 416)
(4 802)
(4 862)
1 226
3 083
2 394
1 749
Pre-Tax Income
38 763
N/A
37 293
-4%
92 335
+148%
171 567
+86%
230 134
+34%
471 128
+105%
448 843
-5%
436 294
-3%
362 898
-17%
141 733
-61%
83 311
-41%
(1 267)
N/A
34 179
N/A
7 327
-79%
13 187
+80%
25 521
+94%
(63 759)
N/A
Net Income
Tax Provision
(5 035)
(4 404)
(17 520)
(34 744)
(49 082)
(115 989)
(107 822)
(101 959)
(84 222)
(19 281)
(2 933)
19 543
11 710
14 990
9 681
1 914
20 484
Income from Continuing Operations
33 728
32 890
74 815
136 823
181 052
355 139
341 021
334 335
278 676
122 452
80 378
18 276
45 890
22 318
22 868
27 435
(43 274)
Net Income (Common)
33 728
N/A
32 890
-2%
74 815
+127%
136 823
+83%
181 052
+32%
355 139
+96%
341 021
-4%
334 335
-2%
278 676
-17%
122 452
-56%
80 378
-34%
18 276
-77%
45 890
+151%
22 318
-51%
22 868
+2%
27 435
+20%
(43 274)
N/A
EPS (Diluted)
552.91
N/A
530.48
-4%
1 168.97
+120%
1 782.44
+52%
2 392.32
+34%
4 810.09
+101%
4 427.83
-8%
4 341.73
-2%
3 618.08
-17%
1 589.84
-56%
1 046.8
-34%
238.01
-77%
597.42
+151%
289.79
-51%
297.64
+3%
357.09
+20%
-563.26
N/A

See Also

Discover More